Endocrine reviews, 34(1), 130162
Go Deep Freeze: The sweet spot for long-term storage is between -20C and -80C (-4F and -112F)
Why This Approval Matters The approval is expected to deliver several important benefits: Greater patient access to semaglutide therapy
Patients on tirzepatide were twice as likely to lose at least 25% of their body weight, and nearly one in five (19.7%) lost 30% or more, compared to fewer than one in fourteen (6.9%) on semaglutide.[1] Both medications also improved blood pressure, blood sugar, and cholesterol levels, with greater improvements seen in the tirzepatide group, which tracked with the larger weight reduction.[1] The safety profiles were similar
Your GP or diabetes specialist will conduct a comprehensive assessment before initiating treatment and throughout your therapy
Why Does AgeRejuvenation's Medical Weight Loss Team Matter